ClinicalTrials.govpublic full text
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults
hiv infections, cabotegravir (cab), ultra long acting (ula), long acting (la), pharmacokinetics, safety, tolerability, healthy adult, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888419
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.